NLRP3 and allergic asthma: Collectively, these studies highlight a critical role for the activated AhR signaling in the airway epithelial cells in protecting allergic airway inflammation and mucus production, and suggest a novel therapeutic strategy targeting the functional axis of ROS-NLRP3 inflammasome in patients with allergic asthma.